ORGANOGENESIS HOLDINGS INC. Increase (Decrease) in Prepaid Expense and Other Assets
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$4.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$6.46M, a 182.68% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.66M, a 67.69% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$3.12M.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$9.64M, a 366.70% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $183.00K, a 92.82% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.55M, a 74.80% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $10.12M, a 2575.93% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $378.00K, a 1011.76% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.81M 10-Q · filed 2026-08-06 | -$7.92M derived: sum of 3 quarters · filed 2026-08-06 | -$17.57M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $1.66M 10-Q · filed 2026-05-07 | -$1.46M derived: sum of 2 quarters · filed 2026-05-07 | -$11.10M derived: sum of 3 quarters · filed 2026-05-07 | -$3.29M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$12.76M derived: sum of 2 quarters · filed 2026-02-26 | -$4.94M derived: sum of 3 quarters · filed 2026-08-06 | $183.00K 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$9.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.82M derived: sum of 2 quarters · filed 2026-08-06 | $3.30M 10-Q · filed 2025-11-06 | $1.79M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $7.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.94M 10-Q · filed 2026-08-06 | $11.44M derived: sum of 3 quarters · filed 2026-08-06 | $15.05M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $5.12M 10-Q · filed 2026-05-07 | $3.62M derived: sum of 2 quarters · filed 2026-05-07 | $7.24M derived: sum of 3 quarters · filed 2026-05-07 | $3.36M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.11M derived: sum of 2 quarters · filed 2026-02-26 | -$1.77M derived: sum of 3 quarters · filed 2026-02-26 | $2.55M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$263.00K derived: sum of 2 quarters · filed 2025-11-06 | $4.05M 10-Q · filed 2025-11-06 | $9.68M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$3.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $436.00K 10-Q · filed 2025-08-07 | $6.06M derived: sum of 3 quarters · filed 2026-02-26 | $7.68M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $4.32M 10-Q · filed 2025-05-08 | $9.94M derived: sum of 2 quarters · filed 2026-02-26 | $11.56M derived: sum of 3 quarters · filed 2026-02-26 | $9.66M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.24M derived: sum of 2 quarters · filed 2026-02-26 | $5.34M derived: sum of 3 quarters · filed 2026-02-26 | $10.12M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$283.00K derived: sum of 2 quarters · filed 2024-11-12 | $4.49M 10-Q · filed 2024-11-12 | $4.87M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.87M 10-Q · filed 2024-08-08 | $3.25M derived: sum of 3 quarters · filed 2025-02-27 | $1.41M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $4.77M 10-Q · filed 2024-05-09 | $5.15M derived: sum of 2 quarters · filed 2025-02-27 | $3.31M derived: sum of 3 quarters · filed 2025-02-27 | $2.99M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.46M derived: sum of 2 quarters · filed 2025-02-27 | -$1.79M derived: sum of 3 quarters · filed 2025-02-27 | $378.00K 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.17M derived: sum of 2 quarters · filed 2023-11-09 | -$1.00K 10-Q · filed 2023-11-09 | -$65.00K derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.84M 10-Q · filed 2023-08-09 | $1.77M derived: sum of 3 quarters · filed 2024-02-29 | $224.00K derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $2.17M 10-Q · filed 2023-05-10 | $2.10M derived: sum of 2 quarters · filed 2024-02-29 | $550.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.58M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.61M derived: sum of 2 quarters · filed 2024-02-29 | -$588.00K derived: sum of 3 quarters · filed 2024-02-29 | $34.00K 10-K · filed 2024-02-29 | ||
| 2021-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$524.00K derived: sum of 2 quarters · filed 2022-11-09 | $98.00K 10-Q · filed 2022-11-09 | -$1.19M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.65M 10-Q · filed 2022-08-09 | $357.00K derived: sum of 3 quarters · filed 2023-03-01 | $702.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $622.00K 10-Q · filed 2022-05-10 | -$670.00K derived: sum of 2 quarters · filed 2023-03-01 | -$325.00K derived: sum of 3 quarters · filed 2023-03-01 | -$1.12M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$947.00K derived: sum of 2 quarters · filed 2023-03-01 | -$1.74M derived: sum of 3 quarters · filed 2023-03-01 | $355.00K 10-K · filed 2023-03-01 | $971.00K 10-K · filed 2021-03-16 | |
| 2020-09-30 | $345.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$452.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.65M 10-Q · filed 2021-11-09 | $2.26M 10-Q · filed 2020-11-09 | $1.57M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$797.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.30M 10-Q · filed 2021-08-09 | $1.23M derived: sum of 3 quarters · filed 2022-03-01 | $1.14M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $2.10M 10-Q · filed 2021-05-11 | $2.02M derived: sum of 2 quarters · filed 2022-03-01 | $1.94M derived: sum of 3 quarters · filed 2022-03-01 | $1.76M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$160.00K derived: sum of 2 quarters · filed 2022-03-01 | -$338.00K derived: sum of 3 quarters · filed 2022-03-01 | $625.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$264.00K derived: sum of 2 quarters · filed 2020-11-09 | $699.00K 10-Q · filed 2020-11-09 | -$552.00K derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-06-30 | -$178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $785.00K 10-Q · filed 2020-08-10 | -$466.00K derived: sum of 3 quarters · filed 2021-03-16 | $342.00K derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-03-31 | $963.00K 10-Q · filed 2020-05-11 | -$288.00K derived: sum of 2 quarters · filed 2021-03-16 | $520.00K derived: sum of 3 quarters · filed 2021-03-16 | $1.02M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2018-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$443.00K derived: sum of 2 quarters · filed 2021-03-16 | $62.00K derived: sum of 3 quarters · filed 2021-03-16 | $1.41M 10-K · filed 2021-03-16 | ||
| 2018-09-30 | $808.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.31M derived: sum of 2 quarters · filed 2019-11-12 | $2.67M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.86M 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | $1.35M 10-Q · filed 2019-05-10 | |||||
| 2017-12-31 | $2.68M 10-K · filed 2020-03-09 | |||||
| 2016-12-31 | -$1.01M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |